BIO-key International Reports Q2 Earnings with Revenue Growth and Improved Net Loss
In the second quarter of 2026, BIO-key International (NASDAQ: BKYI) reported total revenue of $1.92 million, a 13% increase from the prior-year period driven by strong performance in license fees. License fee revenue rose to $1.2 million, up 53%, while hardware sales declined due to delayed shipments expected later in 2026. The company improved its net loss by 51% year-over-year to $577,000 or $0.56 per share and achieved a gross margin of 87%. BIO-key also strengthened its balance sheet with over $4.5 million in cash following a warrant transaction that raised $2.5 million and reduced debt by $350,000. Looking ahead, management expressed confidence in achieving revenue growth and profitability for the second half of 2026. The company is also expanding internationally, particularly in Europe, the Middle East, and Africa, with national-scale initiatives underway.
Tickers: $BKYI